Jyothy Labs Q1 FY27 profit halves; stock falls 5% in 2026

Jyothy Labs shares slide after Q1 FY27 update

Shares of Jyothy Labs Ltd. traded around 5% lower on Wednesday, August 12, after the company reported a weak set of results for the April-June quarter of FY27. The move put focus back on near-term profitability and the pace of recovery in consumer staples demand. The company operates in the FMCG sector and is classified under Household & Personal Products. The stock is tracked on NSE under JYOTHYLABEQ and on BSE under 532926. The ISIN code mentioned is INE668F01031.

What the market reaction looked like

The decline was described as roughly 5% on the day of the results. Separately, price prints in the same information set showed the stock around the ₹199-₹200 zone. One quote showed ₹200, down ₹0.85 (0.42%), and another showed ₹199.58, down ₹0.41 (0.21%). These snapshots indicate the stock was trading lower around the time the results and related updates were being digested.

Q1 FY27 headline: profit down sharply year-on-year

The most prominent result headline was a sharp year-on-year drop in profitability. Jyothy Labs reported net profit of ₹47.6 crore for the April-June quarter of FY27. This was stated as a 50.8% year-on-year decline compared with ₹96.8 crore in the year-ago quarter. The scale of the decline is what drove the “weak results” characterization alongside the immediate share price reaction.

Other quarterly numbers referenced in the data set

Alongside the headline profit figure, the same compilation also carried a separate set of quarterly metrics for Jyothy Labs. That snapshot listed revenue of ₹717 crore, gross profit of ₹80 crore, and net profit of ₹67 crore, along with QoQ and YoY percentage changes for those lines. It also listed an EPS figure of 9.07, while estimated EPS was shown as unavailable. Because these figures appear in the same bundle but are not presented with identical context as the ₹47.6 crore headline, readers typically cross-check the company’s exchange filing for the exact reported base (standalone versus consolidated) and definitions.

Earnings date and investor call: what the company disclosed

The company also announced an investor and analyst conference call scheduled for Wednesday, August 12, 2026, at 16:00 hours IST. The stated purpose of the call was to discuss the unaudited financial results for the quarter ended June 30, 2026, and the strategic way forward. The call was to be coordinated by ICICI Securities. The disclosure was made under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was filed with BSE Limited and the National Stock Exchange of India Limited on August 5, 2026. The company also pointed investors to its website, www.jyothylabs.com, for further details.

Access details shared for the conference call

The call note included dial-in options for participants. Universal access numbers were listed as +91 22 6280 1144 and +91 22 7115 8045. It also listed toll-free access from Singapore (8001012045), Hong Kong (800964448), UK (08081011573), and USA (18667462133). A “Diamond Pass” registration link was also referenced for online access. For investor queries, ICICI Securities research contacts were provided, including Manoj Menon (Head of Research), Ashutosh Joytiraditya, and Rushad Kapadia.

Management commentary referenced: costs, crude-linked inputs, and pricing

The information set also included commentary that Jyothy Labs expects near-term margin pressure in Q1 FY27. The drivers cited were sharp raw material cost increases, particularly crude-linked inputs, and crude price volatility. A calibrated 4% price increase in March was referenced, with further pricing actions planned depending on input cost trends. The same commentary stated that the company expects to sustain volume growth despite the near-term margin pressures.

Distribution push: plan to add outlets annually

A retail expansion plan was also referenced as part of the company’s operating approach. Jyothy Labs plans continued expansion of its retail footprint by adding 50,000 to 100,000 outlets annually across the country. The stated intent of this expansion was to improve general trade (GT) productivity. In FMCG, distribution reach often has a direct linkage to volumes, especially in household and personal products where repeat purchase is a key driver.

Key facts and datapoints mentioned

Market impact: what investors are likely tracking next

For investors, the immediate market impact was the negative price reaction alongside a steep year-on-year profit decline in the headline. The scheduled earnings call becomes the next focal point because it is positioned to cover performance metrics and the company’s strategic direction. The cost commentary places additional emphasis on how input inflation flows through to operating margins and whether pricing actions can offset it. Distribution expansion plans, including the targeted annual outlet additions, will also be watched for execution as they influence volume delivery over time. Valuation snapshots in the same set put the stock around a P/E of about 28 and a market cap close to ₹9,800 crore, offering a reference point for how the market is pricing near-term uncertainty.

Conclusion

Jyothy Labs’ Q1 FY27 update triggered a decline of about 5% in the stock, with the headline pointing to net profit falling to ₹47.6 crore from ₹96.8 crore a year earlier. Alongside the results reaction, the company has scheduled an investor conference call on August 12, 2026, at 16:00 IST to discuss the quarter ended June 30, 2026. Commentary in the same information set highlighted near-term margin pressure tied to raw material costs, a 4% price increase taken in March, and a continued push to expand retail reach. Investors will look to the call for clarity on margin trajectory, pricing actions, and the operating plan for the rest of FY27.